Ervin Veszprémi
Nessuna posizione attualmente
Profilo
Ervin Veszprémi formerly worked at Medichem SA, as Chief Executive Officer from 2003 to 2014, Invent Invest Holding SL, as Chief Executive Officer from 2015 to 2016, Genmedica Therapeutics SL, as Chairman, Kindred Biosciences, Inc., as Independent Director from 2013 to 2021, Amersham Corp., as Head-Business Unit, Novartis Groupe France SA, as Vice President, Novartis Animal Health US, Inc., as Vice President & Global Head-Marketing in 2002, and Pharmacia Spain SA, as Head-Business Unit.
Mr. Veszprémi received his undergraduate degree from the University of British Columbia.
Precedenti posizioni note di Ervin Veszprémi
| Società | Posizione | Fine |
|---|---|---|
| KINDRED BIOSCIENCES, INC. | Director/Board Member | 27/08/2021 |
Invent Invest Holding SL
 Invent Invest Holding SL Pharmaceuticals: MajorHealth Technology Invent Invest Holding SL engages in the development, production, wholesale, and retail of pharmaceutical products. The company was founded by Fridrik Steinn Kristjansson on January 4, 2005 and is headquartered in Sant Joan Despi, Spain. | Chief Executive Officer | 04/10/2016 |
Medichem SA
 Medichem SA Pharmaceuticals: MajorHealth Technology Medichem SA is a vertically Spanish integrated pharmaceutical company that specializes in the development and manufacture of APIs and FDFs for the generics market. The company is based in Sant Joan Despi, Spain, and has subsidiaries in Spain. The company offers highly potent active pharmaceutical ingredients (HPAPI) manufacturing, from development to cGMP production, and have an R & D laboratory and GMP kilo-lab. Medichem offers specific chlorhexidine transparent aqueous and alcoholic solutions based on chlorhexidine digluconate as an active ingredient, with a wide range of applications such as pharma, biocide, oral care, cosmetics, and veterinary. The company's chlorhexidine wipes are used for general disinfection. The company was founded in 1972, and José Luis Rodríguez has been the CEO of the company since 1996. | Chief Executive Officer | 01/01/2014 |
Novartis Groupe France SA
 Novartis Groupe France SA Financial ConglomeratesFinance Novartis Groupe France SA is a pharmaceutical company. It provides cure for diseases. The company is headquartered in Rueil-Malmaison, France. | Corporate Officer/Principal | - |
Novartis Animal Health US, Inc.
 Novartis Animal Health US, Inc. Pharmaceuticals: MajorHealth Technology Part of Elanco Animal Health, Inc., Novartis Animal Health US, Inc. manufactures pharmaceutical products for animals. The private company is based in Greensboro, NC. | Sales & Marketing | 01/01/2002 |
Formazione di Ervin Veszprémi
| University of British Columbia | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Amersham Corp.
 Amersham Corp. Investment ManagersFinance Founded in 1993 by Andrew Cousin, Amersham Corp. is a private equity firm located in Louisville, Colorado with additional offices in California, Florida, Texas and China. | Finance |
Kindred Biosciences, Inc.
 Kindred Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kindred Biosciences, Inc. is a development-stage biopharmaceutical company, which focuses on saving and improving the lives of pets. The company was founded by Richard Chin and Denise M. Bevers on September 25, 2012 and is headquartered in Burlingame, CA. | Health Technology |
Novartis Groupe France SA
Novartis Groupe France SA Financial ConglomeratesFinance Novartis Groupe France SA is a pharmaceutical company. It provides cure for diseases. The company is headquartered in Rueil-Malmaison, France. | Finance |
Genmedica Therapeutics SL
 Genmedica Therapeutics SL BiotechnologyHealth Technology Genmedica Therapeutics SL engages in the research and development of new treatments for diabetes. Its has developed novel NCE-generating platform to generate dual action, small molecules that act against oxidative stress and inflammation, two specific pathways known to be critical in the root causes of the disease. The company was founded by Alec Humayun Mian and Luc Marti Clauzel on June 21, 2004 and is headquartered in Barcelona, Spain. | Health Technology |
Novartis Animal Health US, Inc.
Novartis Animal Health US, Inc. Pharmaceuticals: MajorHealth Technology Part of Elanco Animal Health, Inc., Novartis Animal Health US, Inc. manufactures pharmaceutical products for animals. The private company is based in Greensboro, NC. | Health Technology |
Medichem SA
Medichem SA Pharmaceuticals: MajorHealth Technology Medichem SA is a vertically Spanish integrated pharmaceutical company that specializes in the development and manufacture of APIs and FDFs for the generics market. The company is based in Sant Joan Despi, Spain, and has subsidiaries in Spain. The company offers highly potent active pharmaceutical ingredients (HPAPI) manufacturing, from development to cGMP production, and have an R & D laboratory and GMP kilo-lab. Medichem offers specific chlorhexidine transparent aqueous and alcoholic solutions based on chlorhexidine digluconate as an active ingredient, with a wide range of applications such as pharma, biocide, oral care, cosmetics, and veterinary. The company's chlorhexidine wipes are used for general disinfection. The company was founded in 1972, and José Luis Rodríguez has been the CEO of the company since 1996. | Health Technology |
| Pharmacia Spain SA | |
Invent Invest Holding SL
Invent Invest Holding SL Pharmaceuticals: MajorHealth Technology Invent Invest Holding SL engages in the development, production, wholesale, and retail of pharmaceutical products. The company was founded by Fridrik Steinn Kristjansson on January 4, 2005 and is headquartered in Sant Joan Despi, Spain. | Health Technology |
- Borsa valori
- Insiders
- Ervin Veszprémi
